Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian equity markets trade in green
Wed, 13 Nov 01:30 pm

Indian markets have recovered some losses and are trading above the dotted line during the post noon session. Barring stocks from IT, FMCG and capital goods, all the sectoral indices are trading in green. Most noticeable upward movement is witnessed in stocks from consumer durables and auto sectors.

BSE-Sensex is up by 78 points and NSE-Nifty is trading up by 22 points. While BSE Mid Cap is trading up by 0.04%, BSE Small Cap index is trading up by 0.02%. The rupee is trading at 63.53 to the US dollar.

Indian pharma stocks are trading mixed. Sun pharmaceuticals and Natco pharmaceuticals are among the leading gainers while Dishman and Ipca labs are leading among the pack of losers. Sun pharma's Israel based subsidiary Taro pharma declared results for the September quarter. Net sales increased by 27.5% YoY. On the operating front, EBITDA margins stood at 63% vs 54% in 2QFY13. This was helped by better gross product mix. The settlement and contingent expenses also declined during the quarter, this too helped in margin improvement. On the bottom line, PAT increased by 46% YoY. Better growth was also attributable to lower forex losses which were down by 70% YoY for the current quarter. Sun pharma is currently trading up by 3%.

Majority of the PSU banking stocks are trading in the green with Bank of Baroda and Bank of India being the major gainers. As per a leading financial daily, India's second largest PSU bank, Punjab national bank (PNB) said that it expects credit growth to reach 12-15% by this fiscal end from 2.5% last year. The growth is expected to be largely driven by demand from retail, agriculture and various other micro, medium and small enterprises. Reportedly, as per the bank's executive director, Rakesh Sethi, things are expected to improve and 2HFY14 will be much better than 1HFY14. Till 1HFY14, the company's credit growth has reached 7%. Further, the bank does not intend to raise lending rates as the cost of deposits has not gone up so far. The bank's Non Performing Assets (NPAs) have also remained at the same levels.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian equity markets trade in green". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.